![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » China’s Sinovac Wins Emergency Use Approval in Indonesia for COVID-19 Vaccine
China’s Sinovac Wins Emergency Use Approval in Indonesia for COVID-19 Vaccine
![emergency use authorization approved](https://www.fdanews.com/ext/resources/test/Drug-Images4/emergency-use-authorization-EUA-approved.gif?t=1586211479&width=430)
January 13, 2021
Indonesia’s Food and Drug Authority has cleared Sinovac’s COVID-19 vaccine, CoronaVac, for emergency use, making it the first country outside of China to authorize the Chinese state-owned drugmaker’s shot.
The Indonesian authority said the inactivated vaccine was found to be 65.3 percent effective based on interim data from a late-stage trial.
Though it has now been approved outside China, skepticism surrounds CoronaVac because of a lack of trial data and widely varying efficacy rates being reported by different countries.
Upcoming Events
-
21Oct